Evidence map›Paper›PMID 20436485›Full record

ArticleNature medicine2010

Derepression of an endogenous long terminal repeat activates the CSF1R proto-oncogene in human lymphoma.

Björn Lamprecht, Korden Walter, Stephan Kreher, Raman Kumar, Michael Hummel, Dido Lenze, Karl Köchert, Mohamed Amine Bouhlel, Julia Richter, Eric Soler and 15 more

Abstract read
PubMed Publisher
In one paragraph

Article in Nature medicine, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 223 papers.

0numbers the graph read from it
0cells of the map it votes in
223citing papers in PubMed
10.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

223 citing papers in PubMed, 374 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Review
  8. Review
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Review
  16. Article
  17. Review
  18. Review
  19. Article
  20. Article

163 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

25 authors at 9 institutions in 5 countries.

Björn Lamprecht[Max-Delbrück-Center for Molecular Medicine, Berlin, Germany.
Korden Walter
Stephan Kreher
Raman Kumar
Michael Hummel
Dido Lenze
Karl Köchert
Mohamed Amine Bouhlel
Julia Richter
Eric Soler
Ralph Stadhouders
Korinna Jöhrens
Kathrin D Wurster
David F Callen
Michael F Harte
Maciej Giefing
Rachael Barlow
Harald Stein
Ioannis Anagnostopoulos
Martin Janz
Peter N Cockerill
Reiner Siebert
Bernd Dörken
Constanze Bonifer
Stephan Mathas
Charité - Universitätsmedizin Berlin · DEMax Delbrück Center · DEUniversity of Leeds · GBErasmus MC · NLSt James's University Hospital · GBUniversity Hospital Schleswig-Holstein · DECentre for Cancer Biology · AUUniversity of Adelaide · AUUniversity of Lübeck · DE

Funding

Cancer Research UK
6 · The paper itself

Abstract

Mammalian genomes contain many repetitive elements, including long terminal repeats (LTRs), which have long been suspected to have a role in tumorigenesis. Here we present evidence that aberrant LTR activation contributes to lineage-inappropriate gene expression in transformed human cells and that such gene expression is central for tumor cell survival. We show that B cell-derived Hodgkin's lymphoma cells depend on the activity of the non-B, myeloid-specific proto-oncogene colony-stimulating factor 1 receptor (CSF1R). In these cells, CSF1R transcription initiates at an aberrantly activated endogenous LTR of the MaLR family (THE1B). Derepression of the THE1 subfamily of MaLR LTRs is widespread in the genome of Hodgkin's lymphoma cells and is associated with impaired epigenetic control due to loss of expression of the corepressor CBFA2T3. Furthermore, we detect LTR-driven CSF1R transcripts in anaplastic large cell lymphoma, in which CSF1R is known to be expressed aberrantly. We conclude that LTR derepression is involved in the pathogenesis of human lymphomas, a finding that might have diagnostic, prognostic and therapeutic implications.

Indexed as

Terminal Repeat SequencesColony-Stimulating FactorsGene ExpressionHodgkin DiseaseHumansLymphomaLymphoma, B-CellMacrophage Colony-Stimulating FactorPhosphoproteinsProto-Oncogene MasProto-OncogenesRepressor ProteinsTumor Suppressor ProteinsCBFA2T3 protein, humanColony-Stimulating FactorsMacrophage Colony-Stimulating FactorMAS1 protein, humanPhosphoproteinsProto-Oncogene MasRepressor ProteinsTumor Suppressor Proteins

Identifiers

PMID20436485
OpenAlexW2074637575

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.